1. 341 Phase 1b/2 study of BXCL701, an oral activator of the systemic innate immunity pathway, combined with pembrolizumab (pembro), in men with metastatic castration-resistant prostate cancer (mCRPC). (9th November 2020) Authors: Aggarwal, Rahul; Costin, Dan; Zhang, Jingsong; Monk, Paul; Linch, Mark; Karsh, Lawrence; Healey, Diane; Corsi-Travali, Stefani; Adurthi, Sreenivas; Adedoyin, Adedayo; O'Neill, Vincent Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 341 Phase 1b/2 study of BXCL701, an oral activator of the systemic innate immunity pathway, combined with pembrolizumab (pembro), in men with metastatic castration-resistant prostate cancer (mCRPC). (9th November 2020) Authors: Aggarwal, Rahul; Costin, Dan; Zhang, Jingsong; Monk, Paul; Linch, Mark; Karsh, Lawrence; Healey, Diane; Corsi-Travali, Stefani; Adurthi, Sreenivas; Adedoyin, Adedayo; O'Neill, Vincent Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone‐ and/or Enzalutamide‐Refractory Metastatic Castration‐Resistant Prostate Cancer. (27th February 2018) Authors: Wei, Xiao X.; Siegel, Adam P.; Aggarwal, Rahul; Lin, Amy M.; Friedlander, Terence W.; Fong, Lawrence; Kim, Won; Louttit, Mirela; Chang, Emily; Zhang, Li; Ryan, Charles J. Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association Between Medicare Program Type and Health Care Access, Acute Care Utilization, and Affordability Among Adults With Cardiovascular Disease. Issue 9 (2nd September 2022) Authors: Oseran, Andrew S.; Sun, Tianyu; Aggarwal, Rahul; Kyalwazi, Ashley; Yeh, Robert W.; Wadhera, Rishi K. Journal: Circulation Issue: Volume 15:Issue 9(2022) Page Start: e008762 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing. (2021) Authors: Chen, Emmalyn; Cario, Clinton L.; Leong, Lancelote; Lopez, Karen; Márquez, César P.; Li, Patricia S.; Oropeza, Erica; Tenggara, Imelda; Cowan, Janet; Simko, Jeffry P.; Kageyama, Robin; Wells, Daniel K.; Chan, June M.; Friedlander, Terence; Aggarwal, Rahul; Paris, Pamela L.; Feng, Felix; Carroll, ... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Checkpoint inhibitor is active against large cell neuroendocrine carcinoma with high tumor mutation burden. Issue 1 (19th September 2017) Authors: Wang, Victoria E.; Urisman, Anatoly; Albacker, Lee; Ali, Siraj; Miller, Vincent; Aggarwal, Rahul; Jablons, David Journal: Journal for immunotherapy of cancer Issue: Volume 5:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinical translation of hyperpolarized 13C pyruvate and urea MRI for simultaneous metabolic and perfusion imaging. Issue 1 (10th August 2021) Authors: Qin, Hecong; Tang, Shuyu; Riselli, Andrew M.; Bok, Robert A.; Delos Santos, Romelyn; van Criekinge, Mark; Gordon, Jeremy W.; Aggarwal, Rahul; Chen, Rui; Goddard, Gregory; Zhang, Chunxin Tracy; Chen, Albert; Reed, Galen; Ruscitto, Daniel M.; Slater, James; Sriram, Renuka; Larson, Peder E. Z.; Vign... Journal: Magnetic resonance in medicine Issue: Volume 87:Issue 1(2022) Page Start: 138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer. (2021) Authors: Taza, Fadi; Holler, Albert E.; Fu, Wei; Wang, Hao; Adra, Nabil; Albany, Costantine; Ashkar, Ryan; Cheng, Heather H.; Sokolova, Alexandra O.; Agarwal, Neeraj; Kessel, Adam; Bryce, Alan; Nafissi, Nellie; Barata, Pedro; Sartor, A. Oliver; Bastos, Diogo; Smaletz, Oren; Berchuck, Jacob E.; Taplin, Mar... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Does oropharyngeal administration of colostrum reduce morbidity and mortality in very preterm infants? A randomised parallel‐group controlled trial. (28th April 2021) Authors: Aggarwal, Rahul; Plakkal, Nishad; Bhat, Vishnu Journal: Journal of paediatrics and child health Issue: Volume 57:Number 9(2021) Page Start: 1467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dramatic response to combination pembrolizumab and radiation in metastatic castration resistant prostate cancer. (August 2020) Authors: Han, Harry J.; Li, Yun Rose; Roach, Mack; Aggarwal, Rahul Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗